U.S. Hotel and Resort REITs Stock News

Earlier in May 2026, Beam Therapeutics presented detailed Phase 1/2 BEAM-302 data in alpha-1 antitrypsin deficiency, outlined plans to expand the trial into a pivotal cohort of roughly 50 additional patients, and signaled its intention to pursue an accelerated approval pathway following FDA feedback. The company highlighted that BEAM-302’s one-time base-editing approach corrects the native PiZ mutation in the liver, aiming to restore physiologic alpha-1 antitrypsin responses to inflammation...

IDACORP (IDA) has drawn attention after its recent share performance, with the stock roughly flat over the past 3 months despite being up about 24.6% over the past year. See our latest analysis for IDACORP. With the share price at US$142.65, IDACORP’s 1 year total shareholder return of 24.57% and 5 year total shareholder return of 69.54% point to steady, income driven momentum rather than a sharp rerating, with recent share price moves easing back after that run. If IDACORP’s mix of regulated...

ICL Group Ltd. has reported past first-quarter 2026 results, with sales of US$2,023 million and net income of US$126 million, alongside announcing that Ms. Miri Mishor stepped down as EVP, Global Information Technology, to be succeeded by Ms. Alegra Kilstein in May 2026. The company also raised its quarterly dividend to US$0.0535 per share, up from US$0.0426 a year earlier, highlighting an increased cash return to shareholders. We’ll now examine how ICL’s stronger quarterly earnings and...

The United States market has shown robust performance with a 2.5% increase over the last week and a remarkable 26% rise in the past year, while earnings are projected to grow by 17% annually. In this thriving environment, identifying stocks that may be trading below their estimated value can offer compelling opportunities for investors seeking to capitalize on potential growth at attractive prices.

NetScout Systems (NTCT) is back on investor radars after a fresh positive earnings surprise, with results topping consensus estimates and recent analyst revisions and rankings pointing to shifting expectations around the stock. See our latest analysis for NetScout Systems. The earnings beat and a run of positive surprises have coincided with strong momentum, with a 30-day share price return of 26.64% and a 1-year total shareholder return of 79.01%, suggesting sentiment has shifted firmly in...

Ryerson Holding (RYZ) has drawn fresh attention after its recent share move, with the stock up 2.5% on the day and 12.5% over the past week, prompting closer scrutiny from investors. See our latest analysis for Ryerson Holding. Set against a 1 year total shareholder return of 30.36% and a 3 year total shareholder return that declined 13.18%, the recent 12.51% 7 day share price return around US$27.35 suggests momentum has picked up again, even though the 90 day share price return is down...

New Mexico regulators have approved Southwestern Public Service Co., an Xcel Energy (XEL) subsidiary, to invest about US$9.38b in 3.8 GW of new utility-owned generation, as well as a delayed retirement of the Tolk coal plant. See our latest analysis for Xcel Energy. At a share price of US$80.78, Xcel Energy has delivered an 8.17% year to date share price return and a 19.38% total shareholder return over the past year. This suggests momentum has been improving as regulators back large scale...

DoubleVerify Holdings (DV) recently announced two product launches that expand its media verification platform, adding global post-bid measurement on LinkedIn Audience Network and AI-driven pre-screen content controls on Meta Threads. See our latest analysis for DoubleVerify Holdings. Despite the recent LinkedIn and Meta Threads product launches, DoubleVerify’s share price has been under pressure, with a 30 day share price return down 11.11% and a 1 year total shareholder return down 28.30%...

The United States market has shown robust performance recently, climbing 2.5% in the last 7 days and achieving a 26% increase over the past year, with earnings projected to grow by 17% annually. In this favorable environment, growth companies with significant insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best.

Over the last 7 days, the United States market has risen by 2.5%, and over the past year, it has climbed an impressive 26%, with earnings expected to grow by 17% annually in the coming years. In such a thriving market environment, identifying stocks that combine affordability with growth potential is key to making informed investment decisions. While penny stocks may seem like a term from a bygone era, they continue to offer opportunities for investors willing to explore smaller or newer...

The United States market has shown robust performance, rising 2.5% over the last week and climbing 26% in the past year, with earnings projected to grow by 17% annually. In this thriving environment, identifying stocks that are not only promising but also underappreciated can provide unique opportunities for investors seeking to capitalize on emerging growth potential.

The United States market has shown impressive growth, rising 2.5% over the last week and 26% over the past year, with earnings projected to increase by 17% annually. In this thriving environment, selecting dividend stocks that offer both stability and potential for income can be a strategic move to enhance your portfolio.

Clinical trial update puts Enhanced Group (ENHA) in focus Enhanced Group (ENHA) is attracting fresh attention after releasing aggregate clinical data from its IRB approved ASCEND001 trial and moving into a five year monitoring phase shortly before the inaugural Enhanced Games. See our latest analysis for Enhanced Group. Despite the clinical trial milestone and new partnerships around Live Enhanced, the stock’s short term momentum has been weak, with the 7 day share price return down 42.4% and...

Dana (DAN) released Q1 2026 results, reporting sales of US$1,868 million and net income of US$1,087 million, compared with US$1,781 million and US$25 million a year earlier, refocusing attention on the stock’s profitability profile. See our latest analysis for Dana. The Q1 earnings release has come alongside a sharp shift in sentiment, with the stock delivering a 41.04% year to date share price return and a very large 3 year total shareholder return. However, the 30 day share price return is...

In early May 2026, Planet Fitness reported softer-than-expected membership growth, lowered its 2026 revenue and earnings guidance, and paused a planned nationwide Black Card price increase amid operational headwinds. At the same time, multiple law firms launched investigations into whether the company adequately disclosed risks around its marketing pivot, highlighting growing scrutiny of Planet Fitness’s growth story and communications. Now we’ll explore how weaker-than-expected membership...

Recent analyst commentary around Sunstone Hotel Investors (SHO) has focused on its record of outperforming earnings expectations in each of the past four quarters, with upgrades and positive estimate revisions drawing fresh attention to the stock. See our latest analysis for Sunstone Hotel Investors. That bullish sentiment has been reflected in the share price, with a 1-month share price return of 12.66%, 90-day return of 15.90% and year-to-date return of 18.95%. The 1-year total shareholder...

AnaptysBio (ANAB) has attracted fresh attention after recent share price moves, prompting investors to reassess how its clinical-stage immunology pipeline and current valuation fit into their broader biotech exposure. See our latest analysis for AnaptysBio. Recent trading has cooled slightly, with the share price down 3.3% over the past week and 1.9% over the past month. However, the year to date share price return of 28.5% and very large 1 year total shareholder return of about 4.3x suggest...

Park Hotels & Resorts recently reported Q1 2026 results that exceeded expectations, including a 5.5% year-over-year RevPAR increase excluding the Royal Palm South Beach Hotel, and completed the US$18,000,000 sale of the Hilton Seattle Airport Hotel as part of its non-core asset reduction efforts. This combination of stronger operating performance and continued pruning of lower-priority properties highlights management’s ongoing push to concentrate the portfolio on higher-quality,...

In May 2026, Deluxe announced a merchant services partnership with Dollar Bank, using its cloud infrastructure and data capabilities to support payment acceptance for Dollar Bank’s business clients across its 91 branches and approximately US$12.20 billion in assets. This agreement underlines Deluxe’s push deeper into the community bank segment, where embedded payment solutions can broaden its reach among small and mid-sized business customers. We’ll now examine how this Dollar Bank...

KULR Technology Group (KULR) is back in focus after a string of aerospace and drone battery announcements, including work on NASA-standard systems for Argo Space Corp and integration of Factorial’s solid-state and lithium‑metal cells. See our latest analysis for KULR Technology Group. The recent aerospace and drone contracts have arrived alongside sharp near term momentum, with a 30 day share price return of 83.82% and a 7 day gain of 22.04%. However, the 1 year total shareholder return is...

On May 19, 2026, CONMED Corporation’s board amended and restated its bylaws and appointed Kimberly Lockwood as Interim Corporate Controller and Principal Accounting Officer, while also naming veteran medtech executives Celine Martin and Jeff Mirviss to its board, effective July 1, 2026, expanding the board to nine directors. The combination of updated governance rules and the addition of directors with long tenures at Johnson & Johnson and Boston Scientific signals a sharpened focus on board...

NeoGenomics overview after recent share performance NeoGenomics (NEO) has drawn fresh attention after a mixed stretch in the stock, with a gain over the past month contrasting with a decline in the past 3 months and year to date. See our latest analysis for NeoGenomics. The recent 30 day share price return of 11.82% follows earlier weakness, with the 90 day share price return down 5.60% and the 3 year total shareholder return down 45.53%. This suggests improving short term momentum after a...

Recent performance snapshot for Liberty Energy Liberty Energy (LBRT) has drawn investor attention after a 69.2% year to date total return and a 176.2% total return over the past year, alongside annual revenue of US$4,049.8m and net income of US$150.3m. See our latest analysis for Liberty Energy. Recent trading shows some cooling after a strong run, with the share price slipping 3.5% over the past week and 2.4% over the past month. Even so, it has delivered a 12.6% 90 day share price return...

Coherent (COHR) is drawing investor interest after a strong share price move over the past year, with total return around 270%. This raises fresh questions about how its current valuation lines up with its fundamentals. See our latest analysis for Coherent. The recent 7.84% 7 day share price return and 13.47% 30 day share price return suggest momentum has been building, while the 1 year total shareholder return of very large magnitude puts the current US$381.35 share price in a very different...